{"transactions":[{"id":943290,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-08T16:20:02.000Z","date":"2026-01-06","kind":"sale","planned":false,"acquired":false,"shares":23766,"price":6.8197,"value":162076.9902,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":323530,"source":{"system":"sec-edgar","filing":"0001453687-26-000047","document":"wk-form4_1767907199.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368726000047/wk-form4_1767907199.xml","form_type":"4"}},{"id":946866,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-06T16:19:20.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":415700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 25% on January 2, 2027. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":415700,"derivative":{"exercise_price":6.76,"expiration_date":"2036-01-01","underlying":"Common  Stock","underlying_shares":415700},"source":{"system":"sec-edgar","filing":"0001453687-26-000038","document":"wk-form4_1767734357.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368726000038/wk-form4_1767734357.xml","form_type":"4"}},{"id":946865,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-06T16:19:20.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":143200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2027. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2030."}],"balance_after":347296,"source":{"system":"sec-edgar","filing":"0001453687-26-000038","document":"wk-form4_1767734357.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368726000038/wk-form4_1767734357.xml","form_type":"4"}},{"id":1308157,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-07T20:04:59.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":8708,"price":16.8322,"value":146574.7976,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":204096,"source":{"system":"sec-edgar","filing":"0001453687-25-000036","document":"wk-form4_1736298292.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368725000036/wk-form4_1736298292.xml","form_type":"4"}},{"id":1308156,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-07T20:04:59.000Z","date":"2025-01-03","kind":"sale","planned":false,"acquired":false,"shares":8563,"price":16.7219,"value":143189.6297,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":212804,"source":{"system":"sec-edgar","filing":"0001453687-25-000036","document":"wk-form4_1736298292.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368725000036/wk-form4_1736298292.xml","form_type":"4"}},{"id":1310830,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-06T16:21:27.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":169100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029."}],"balance_after":169100,"derivative":{"exercise_price":16.93,"expiration_date":"2035-01-01","underlying":"Common  Stock","underlying_shares":169100},"source":{"system":"sec-edgar","filing":"0001453687-25-000028","document":"wk-form4_1736198480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368725000028/wk-form4_1736198480.xml","form_type":"4"}},{"id":1310829,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-06T16:21:27.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":57500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the \"Reverse Stock Split\").  The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":221367,"source":{"system":"sec-edgar","filing":"0001453687-25-000028","document":"wk-form4_1736198480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368725000028/wk-form4_1736198480.xml","form_type":"4"}},{"id":1687973,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-04T17:07:39.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":5971000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028."}],"balance_after":5971000,"derivative":{"exercise_price":0.6552,"expiration_date":"2034-01-01","underlying":"Common  Stock","underlying_shares":5971000},"source":{"system":"sec-edgar","filing":"0001453687-24-000025","document":"wk-form4_1704406045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368724000025/wk-form4_1704406045.xml","form_type":"4"}},{"id":1687972,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-04T17:07:39.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":4654100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028."}],"balance_after":4916056,"source":{"system":"sec-edgar","filing":"0001453687-24-000025","document":"wk-form4_1704406045.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368724000025/wk-form4_1704406045.xml","form_type":"4"}},{"id":1740886,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1275000,"price":0.93,"value":1185750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"This option, which provided for vesting as to 25% of the shares on January 2, 2024 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger, in exchange for a cash payment of $1,185,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.13,"expiration_date":"2033-01-01","underlying":"Common Stock","underlying_shares":1275000},"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1740885,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1056100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This option, which provided for vesting as to 25% of the shares on January 3, 2023 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"This option, which provided for vesting as to 25% of the shares on January 3, 2023 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":3.31,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":1056100},"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1740884,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":163000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This option, which provided for vesting as to 25% of the shares on September 24, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"This option, which provided for vesting as to 25% of the shares on September 24, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":4.32,"expiration_date":"2031-09-23","underlying":"Common Stock","underlying_shares":163000},"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1740883,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":670000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This option, which provided for vesting as to 25% of the shares on January 4, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This option, which provided for vesting as to 25% of the shares on January 4, 2022 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":2.99,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":670000},"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1740882,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This option, which provided for vesting as to 25% of the shares on  July 1, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option, which provided for vesting as to 25% of the shares on  July 1, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":2.84,"expiration_date":"2030-06-30","underlying":"Common  Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1740881,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":600000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This option, which provided for vesting as to 25% of the shares on January 2, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option, which provided for vesting as to 25% of the shares on January 2, 2021 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":2.3,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1740880,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":400000,"price":0.31,"value":124000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, which provided for vesting as to 50% of the shares on October 7, 2020 and the remaining 50% of the shares on October 7, 2021, was canceled in the Merger, in exchange for a cash payment of $124,000, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2029-10-06","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1740879,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":330000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This option, which provided for vesting as to 25% of the shares on February 25, 2020 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, which provided for vesting as to 25% of the shares on February 25, 2020 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":2.2,"expiration_date":"2029-02-24","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1740878,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option, which provided for vesting as to 25% of the shares on December 1, 2019 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, which provided for vesting as to 25% of the shares on December 1, 2019 with the remainder of the shares vesting in 36 substantially equal monthly installments thereafter, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":6.03,"expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1740877,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":282800,"price":2.06,"value":582568.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This unvested restricted stock, which was granted on January 2, 2023, was canceled in the Merger, in exchange for $582,568, representing $2.06 per share, the Cash-out Amount as applied in the Merger."}],"balance_after":261956,"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1740876,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":169725,"price":2.06,"value":349633.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This unvested restricted stock, which was granted on January 3, 2022, was canceled in the Merger, in exchange for $349,633.50, representing $2.06 per share, the Cash-out Amount as applied in the Merger."}],"balance_after":544756,"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1740875,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13600,"price":2.06,"value":28016.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This unvested restricted stock, which was granted on September 24, 2021, was canceled in the Merger, in exchange for $28,016, representing $2.06 per share, the Cash-out Amount as applied in the Merger."}],"balance_after":714481,"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1740874,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-15T17:26:14.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":55000,"price":2.06,"value":113300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This unvested restricted stock, which was granted on January 4, 2021, was canceled in the merger (the \"Merger\") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc., in exchange for $113,300, representing $2.06 per share, the Cash-out Amount as applied in the Merger."}],"balance_after":728081,"source":{"system":"sec-edgar","filing":"0001453687-23-000088","document":"wk-form4_1700087164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000088/wk-form4_1700087164.xml","form_type":"4"}},{"id":1773356,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-26T18:01:00.000Z","date":"2023-09-25","kind":"sale","planned":false,"acquired":false,"shares":2932,"price":1.06,"value":3107.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":783081,"source":{"system":"sec-edgar","filing":"0001453687-23-000068","document":"wk-form4_1695765647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000068/wk-form4_1695765647.xml","form_type":"4"}},{"id":2060522,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-06T17:16:31.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":77,"price":1.115,"value":85.855,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":786013,"source":{"system":"sec-edgar","filing":"0001453687-23-000035","document":"wf-form4_167304337502065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000035/wf-form4_167304337502065.xml","form_type":"4"}},{"id":2060521,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-06T17:16:31.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":13396,"price":1.1293,"value":15128.1028,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":786090,"source":{"system":"sec-edgar","filing":"0001453687-23-000035","document":"wf-form4_167304337502065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000035/wf-form4_167304337502065.xml","form_type":"4"}},{"id":2060520,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-06T17:16:31.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":48,"price":1.145,"value":54.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":799486,"source":{"system":"sec-edgar","filing":"0001453687-23-000035","document":"wf-form4_167304337502065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000035/wf-form4_167304337502065.xml","form_type":"4"}},{"id":2060519,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-06T17:16:31.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":27549,"price":1.1337,"value":31232.3013,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":799534,"source":{"system":"sec-edgar","filing":"0001453687-23-000035","document":"wf-form4_167304337502065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000035/wf-form4_167304337502065.xml","form_type":"4"}},{"id":2068127,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-04T17:03:45.000Z","date":"2023-01-02","kind":"grant","acquired":true,"shares":1275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 25% on January 2, 2024. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":1275000,"derivative":{"exercise_price":1.13,"expiration_date":"2033-01-01","underlying":"Common Stock","underlying_shares":1275000},"source":{"system":"sec-edgar","filing":"0001453687-23-000022","document":"wf-form4_167286979042642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000022/wf-form4_167286979042642.xml","form_type":"4"}},{"id":2068126,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-01-04T17:03:45.000Z","date":"2023-01-02","kind":"grant","acquired":true,"shares":282800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2024. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2027."}],"balance_after":827083,"source":{"system":"sec-edgar","filing":"0001453687-23-000022","document":"wf-form4_167286979042642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368723000022/wf-form4_167286979042642.xml","form_type":"4"}},{"id":2093343,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-07T16:17:17.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":4522,"price":1.33,"value":6014.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."}],"balance_after":544283,"source":{"system":"sec-edgar","filing":"0001453687-22-000147","document":"wf-form4_167044782270489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000147/wf-form4_167044782270489.xml","form_type":"4"}},{"id":2096283,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-12-05T16:24:50.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award is fully vested and has no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award is fully vested and has no expiration date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10938},"source":{"system":"sec-edgar","filing":"0001453687-22-000145","document":"wf-form4_167027547181099.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000145/wf-form4_167027547181099.xml","form_type":"4"}},{"id":2096282,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-05T16:24:50.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":548805,"source":{"system":"sec-edgar","filing":"0001453687-22-000145","document":"wf-form4_167027547181099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000145/wf-form4_167027547181099.xml","form_type":"4"}},{"id":2148719,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-30T19:37:06.000Z","date":"2022-09-28","kind":"sale","acquired":false,"shares":2692,"price":1.6605,"value":4470.066,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.6604 to $1.6605. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":537867,"source":{"system":"sec-edgar","filing":"0001453687-22-000131","document":"wf-form4_166458101110775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000131/wf-form4_166458101110775.xml","form_type":"4"}},{"id":2165772,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-09-06T20:37:41.000Z","date":"2022-09-01","kind":"exercise","acquired":false,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."}],"balance_after":10938,"derivative":{"underlying":"Common Stock","underlying_shares":10937},"source":{"system":"sec-edgar","filing":"0001453687-22-000129","document":"wf-form4_166251104851877.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000129/wf-form4_166251104851877.xml","form_type":"4"}},{"id":2165771,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-06T20:37:41.000Z","date":"2022-09-02","kind":"sale","acquired":false,"shares":4768,"price":1.8478,"value":8810.3104,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.825 to $1.855. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":540559,"source":{"system":"sec-edgar","filing":"0001453687-22-000129","document":"wf-form4_166251104851877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000129/wf-form4_166251104851877.xml","form_type":"4"}},{"id":2165770,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-06T20:37:41.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":545327,"source":{"system":"sec-edgar","filing":"0001453687-22-000129","document":"wf-form4_166251104851877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000129/wf-form4_166251104851877.xml","form_type":"4"}},{"id":2218752,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-30T20:05:24.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the Options shall vest on June 28, 2023, and the remainder of the Options shall vest in equal monthly installments over the following twelve months, such that all of the Options shall be vested on June 28, 2024, subject to the Reporting Person's continued service relationship with the Company on each such vesting date."}],"balance_after":48000,"derivative":{"exercise_price":1.74,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001209191-22-039976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000120919122039976/doc4.xml","form_type":"4"}},{"id":2244941,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-06-03T16:44:19.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."}],"balance_after":21875,"derivative":{"underlying":"Common Stock","underlying_shares":10938},"source":{"system":"sec-edgar","filing":"0001453687-22-000099","document":"wf-form4_165428903107199.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000099/wf-form4_165428903107199.xml","form_type":"4"}},{"id":2244940,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-06-03T16:44:19.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":534390,"source":{"system":"sec-edgar","filing":"0001453687-22-000099","document":"wf-form4_165428903107199.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000099/wf-form4_165428903107199.xml","form_type":"4"}},{"id":2354940,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-03-03T16:35:40.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."}],"balance_after":32813,"derivative":{"underlying":"Common Stock","underlying_shares":10937},"source":{"system":"sec-edgar","filing":"0001453687-22-000044","document":"wf-form4_164634331527341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000044/wf-form4_164634331527341.xml","form_type":"4"}},{"id":2354939,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-03T16:35:40.000Z","date":"2022-03-02","kind":"sale","acquired":false,"shares":5443,"price":1.8121,"value":9863.2603,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.80 to $1.825. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":523452,"source":{"system":"sec-edgar","filing":"0001453687-22-000044","document":"wf-form4_164634331527341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000044/wf-form4_164634331527341.xml","form_type":"4"}},{"id":2354938,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-03T16:35:40.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":528895,"source":{"system":"sec-edgar","filing":"0001453687-22-000044","document":"wf-form4_164634331527341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000044/wf-form4_164634331527341.xml","form_type":"4"}},{"id":2440175,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-07T16:17:48.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":13597,"price":3.0859,"value":41958.9823,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.99 to $3.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":517958,"source":{"system":"sec-edgar","filing":"0001453687-22-000031","document":"wf-form4_164159025635618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000031/wf-form4_164159025635618.xml","form_type":"4"}},{"id":2444227,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-05T16:32:03.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":1056100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 25% on January 3, 2023. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":1056100,"derivative":{"exercise_price":3.31,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":1056100},"source":{"system":"sec-edgar","filing":"0001453687-22-000016","document":"wf-form4_164141830853581.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000016/wf-form4_164141830853581.xml","form_type":"4"}},{"id":2444226,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-05T16:32:03.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":226300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 3, 2023. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 3, 2026."}],"balance_after":531555,"source":{"system":"sec-edgar","filing":"0001453687-22-000016","document":"wf-form4_164141830853581.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368722000016/wf-form4_164141830853581.xml","form_type":"4"}},{"id":2473574,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-14T17:16:03.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":17196,"price":2.9869,"value":51362.7324,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.94 to $3.0201. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":305255,"source":{"system":"sec-edgar","filing":"0001453687-21-000183","document":"wf-form4_163952015012703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000183/wf-form4_163952015012703.xml","form_type":"4"}},{"id":2477342,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-10T17:06:45.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 4, 2021, the reporting person was granted performance based restricted stock units for an aggregate of 75,000 shares of the Issuer's common stock (the \"Performance RSUs\"), which were earned based on the achievement of two separate performance conditions related to the Issuer's operating and research and development activities. The compensation committee of the board of directors of the Issuer has determined that the second of the performance conditions has been met, and accordingly 37,500 Performance RSUs vested on December 8, 2021,"}],"balance_after":322451,"source":{"system":"sec-edgar","filing":"0001453687-21-000173","document":"wf-form4_163917398636442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000173/wf-form4_163917398636442.xml","form_type":"4"}},{"id":2486108,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-12-03T16:28:40.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."}],"balance_after":43750,"derivative":{"underlying":"Common Stock","underlying_shares":10938},"source":{"system":"sec-edgar","filing":"0001453687-21-000158","document":"wf-form4_163856690437223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000158/wf-form4_163856690437223.xml","form_type":"4"}},{"id":2486107,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-03T16:28:40.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":4746,"price":2.9635,"value":14064.771,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.94 to $2.99. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":284951,"source":{"system":"sec-edgar","filing":"0001453687-21-000158","document":"wf-form4_163856690437223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000158/wf-form4_163856690437223.xml","form_type":"4"}},{"id":2486106,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-03T16:28:40.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":289697,"source":{"system":"sec-edgar","filing":"0001453687-21-000158","document":"wf-form4_163856690437223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000158/wf-form4_163856690437223.xml","form_type":"4"}},{"id":2541724,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-15T18:07:06.000Z","date":"2021-10-13","kind":"sale","acquired":false,"shares":15313,"price":4.39,"value":67224.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.35 to $4.475. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":278759,"source":{"system":"sec-edgar","filing":"0001453687-21-000141","document":"wf-form4_163433561231518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000141/wf-form4_163433561231518.xml","form_type":"4"}},{"id":2549171,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-05T16:25:39.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 4, 2021, the reporting person was granted performance based restricted stock units for an aggregate of 75,000 shares of the Issuer's common stock (the \"Performance RSUs\"), which may be earned based on the achievement of two separate performance conditions related to the Issuer's operating and research and development activities. Any Performance RSUs will generally vest in two equal installments upon the dates of achievement of each of the two performance conditions, subject to continued employment, so long as each performance condition is met before December 31, 2021. The compensation committee of the board of directors of the Issuer has determined that the first of the performance conditions has been met, and accordingly 37,500 Performance RSUs vested on October 1, 2021."}],"balance_after":294072,"source":{"system":"sec-edgar","filing":"0001453687-21-000132","document":"wf-form4_163346550161233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000132/wf-form4_163346550161233.xml","form_type":"4"}},{"id":2557746,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-28T16:32:04.000Z","date":"2021-09-24","kind":"grant","acquired":true,"shares":163000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 25% on September 24, 2022. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":163000,"derivative":{"exercise_price":4.32,"expiration_date":"2031-09-23","underlying":"Common Stock","underlying_shares":163000},"source":{"system":"sec-edgar","filing":"0001453687-21-000120","document":"wf-form4_163286110389016.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000120/wf-form4_163286110389016.xml","form_type":"4"}},{"id":2557745,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-28T16:32:04.000Z","date":"2021-09-24","kind":"grant","acquired":true,"shares":27200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on September 24, 2022. The remainder of the underlying shares will vest in three equalannual installments thereafter so that the underlying shares will be fully vested on September 24, 2025."}],"balance_after":256572,"source":{"system":"sec-edgar","filing":"0001453687-21-000120","document":"wf-form4_163286110389016.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000120/wf-form4_163286110389016.xml","form_type":"4"}},{"id":2579480,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-09-03T16:18:02.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."}],"balance_after":54688,"derivative":{"underlying":"Common Stock","underlying_shares":10937},"source":{"system":"sec-edgar","filing":"0001453687-21-000107","document":"wf-form4_163070026398370.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000107/wf-form4_163070026398370.xml","form_type":"4"}},{"id":2579479,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-03T16:18:02.000Z","date":"2021-09-02","kind":"sale","acquired":false,"shares":4523,"price":4.51,"value":20398.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.4707 to $4.57. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":229372,"source":{"system":"sec-edgar","filing":"0001453687-21-000107","document":"wf-form4_163070026398370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000107/wf-form4_163070026398370.xml","form_type":"4"}},{"id":2579478,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-09-03T16:18:02.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":233895,"source":{"system":"sec-edgar","filing":"0001453687-21-000107","document":"wf-form4_163070026398370.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000107/wf-form4_163070026398370.xml","form_type":"4"}},{"id":2683531,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-06-03T16:30:28.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."}],"balance_after":65625,"derivative":{"underlying":"Common Stock","underlying_shares":10938},"source":{"system":"sec-edgar","filing":"0001453687-21-000081","document":"wf-form4_162275218310282.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000081/wf-form4_162275218310282.xml","form_type":"4"}},{"id":2683530,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-03T16:30:28.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":4806,"price":4.378,"value":21040.668,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.34 to $4.385. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":222958,"source":{"system":"sec-edgar","filing":"0001453687-21-000081","document":"wf-form4_162275218310282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000081/wf-form4_162275218310282.xml","form_type":"4"}},{"id":2683529,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-03T16:30:28.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":227764,"source":{"system":"sec-edgar","filing":"0001453687-21-000081","document":"wf-form4_162275218310282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000081/wf-form4_162275218310282.xml","form_type":"4"}},{"id":2814248,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-03-03T17:21:04.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date."}],"balance_after":76563,"derivative":{"underlying":"Common Stock","underlying_shares":10937},"source":{"system":"sec-edgar","filing":"0001453687-21-000023","document":"wf-form4_161481004616254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000023/wf-form4_161481004616254.xml","form_type":"4"}},{"id":2814247,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T17:21:04.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":5461,"price":4.2588,"value":23257.3068,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.24 to $4.285. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":216826,"source":{"system":"sec-edgar","filing":"0001453687-21-000023","document":"wf-form4_161481004616254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000023/wf-form4_161481004616254.xml","form_type":"4"}},{"id":2814246,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-03T17:21:04.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":222287,"source":{"system":"sec-edgar","filing":"0001453687-21-000023","document":"wf-form4_161481004616254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000023/wf-form4_161481004616254.xml","form_type":"4"}},{"id":2916136,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-06T16:49:15.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":670000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests as to 25% on January 4, 2022. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":670000,"derivative":{"exercise_price":2.99,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":670000},"source":{"system":"sec-edgar","filing":"0001453687-21-000014","document":"wf-form4_160996973826334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000014/wf-form4_160996973826334.xml","form_type":"4"}},{"id":2916135,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-06T16:49:15.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 4, 2022. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 4, 2025."}],"balance_after":211350,"source":{"system":"sec-edgar","filing":"0001453687-21-000014","document":"wf-form4_160996973826334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368721000014/wf-form4_160996973826334.xml","form_type":"4"}},{"id":2958768,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-12-03T16:22:46.000Z","date":"2020-12-01","kind":"exercise","acquired":false,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit vests as to 25% on December 1, 2019.  The remainder of the units will vest in twelve substantially equal quarterly installments thereafter.  The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit vests as to 25% on December 1, 2019.  The remainder of the units will vest in twelve substantially equal quarterly installments thereafter.  The restricted stock units have no expiration date."}],"balance_after":87500,"derivative":{"underlying":"Common Stock","underlying_shares":10938},"source":{"system":"sec-edgar","filing":"0001453687-20-000131","document":"wf-form4_160703055313759.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000131/wf-form4_160703055313759.xml","form_type":"4"}},{"id":2958767,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-03T16:22:46.000Z","date":"2020-12-02","kind":"sale","acquired":false,"shares":3323,"price":3.3506,"value":11134.0438,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.335 to $3.375. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":101350,"source":{"system":"sec-edgar","filing":"0001453687-20-000131","document":"wf-form4_160703055313759.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000131/wf-form4_160703055313759.xml","form_type":"4"}},{"id":2958766,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-12-03T16:22:46.000Z","date":"2020-12-01","kind":"exercise","acquired":true,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":104673,"source":{"system":"sec-edgar","filing":"0001453687-20-000131","document":"wf-form4_160703055313759.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000131/wf-form4_160703055313759.xml","form_type":"4"}},{"id":3039555,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-09-03T16:29:34.000Z","date":"2020-09-01","kind":"exercise","acquired":false,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit vests as to 25% on December 1, 2019.  The remainder of the units will vest in twelve substantially equal quarterly installments thereafter.  The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit vests as to 25% on December 1, 2019.  The remainder of the units will vest in twelve substantially equal quarterly installments thereafter.  The restricted stock units have no expiration date."}],"balance_after":98438,"derivative":{"underlying":"Common Stock","underlying_shares":10937},"source":{"system":"sec-edgar","filing":"0001453687-20-000103","document":"wf-form4_159916495956344.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000103/wf-form4_159916495956344.xml","form_type":"4"}},{"id":3039554,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-03T16:29:34.000Z","date":"2020-09-02","kind":"sale","acquired":false,"shares":3364,"price":2.3884,"value":8034.5776,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.36 to $2.41. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":93735,"source":{"system":"sec-edgar","filing":"0001453687-20-000103","document":"wf-form4_159916495956344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000103/wf-form4_159916495956344.xml","form_type":"4"}},{"id":3039553,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-09-03T16:29:34.000Z","date":"2020-09-01","kind":"exercise","acquired":true,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":97099,"source":{"system":"sec-edgar","filing":"0001453687-20-000103","document":"wf-form4_159916495956344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000103/wf-form4_159916495956344.xml","form_type":"4"}},{"id":3089049,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-07-06T16:10:55.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 25% on July 1, 2021. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":75000,"derivative":{"exercise_price":2.84,"expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-20-081208","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000110465920081208/a4.xml","form_type":"4"}},{"id":3124553,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-06-03T16:42:34.000Z","date":"2020-06-01","kind":"exercise","acquired":false,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit vests as to 25% on December 1, 2019.  The remainder of the units will vest in twelve substantially equal quarterly installments thereafter.  The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit vests as to 25% on December 1, 2019.  The remainder of the units will vest in twelve substantially equal quarterly installments thereafter.  The restricted stock units have no expiration date."}],"balance_after":109375,"derivative":{"underlying":"Common Stock","underlying_shares":10938},"source":{"system":"sec-edgar","filing":"0001453687-20-000054","document":"wf-form4_159121693539654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000054/wf-form4_159121693539654.xml","form_type":"4"}},{"id":3124552,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-03T16:42:34.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":3253,"price":3.8601,"value":12556.9053,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.83 to $3.90. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":86162,"source":{"system":"sec-edgar","filing":"0001453687-20-000054","document":"wf-form4_159121693539654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000054/wf-form4_159121693539654.xml","form_type":"4"}},{"id":3124551,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-03T16:42:34.000Z","date":"2020-06-01","kind":"exercise","acquired":true,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":89415,"source":{"system":"sec-edgar","filing":"0001453687-20-000054","document":"wf-form4_159121693539654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000054/wf-form4_159121693539654.xml","form_type":"4"}},{"id":3233158,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T16:25:44.000Z","date":"2020-03-01","kind":"exercise","acquired":false,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit vests as to 25% on December 1, 2019.  The remainder of the units will vest in twelve substantially equal quarterly installments thereafter.  The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit vests as to 25% on December 1, 2019.  The remainder of the units will vest in twelve substantially equal quarterly installments thereafter.  The restricted stock units have no expiration date."}],"balance_after":120313,"derivative":{"underlying":"Common Stock","underlying_shares":10937},"source":{"system":"sec-edgar","filing":"0001453687-20-000021","document":"wf-form4_158327072572666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000021/wf-form4_158327072572666.xml","form_type":"4"}},{"id":3233157,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-03T16:25:44.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":3374,"price":3.8564,"value":13011.4936,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $3.85 to $3.87. The Reporting Person undertakes to provide upon request to theSEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":78477,"source":{"system":"sec-edgar","filing":"0001453687-20-000021","document":"wf-form4_158327072572666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000021/wf-form4_158327072572666.xml","form_type":"4"}},{"id":3233156,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-03T16:25:44.000Z","date":"2020-03-01","kind":"exercise","acquired":true,"shares":10937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":81851,"source":{"system":"sec-edgar","filing":"0001453687-20-000021","document":"wf-form4_158327072572666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000021/wf-form4_158327072572666.xml","form_type":"4"}},{"id":3318717,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-06T20:06:46.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 25% on January 2, 2021. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":600000,"derivative":{"exercise_price":2.3,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001453687-20-000009","document":"wf-form4_157835918962071.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368720000009/wf-form4_157835918962071.xml","form_type":"4"}},{"id":3354394,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2019-12-03T16:20:01.000Z","date":"2019-12-01","kind":"exercise","acquired":false,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units vested as to 25% on December 1, 2019.  The remainder of the units will vest in twelve substantially equal quarterly installments thereafter.  The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units vested as to 25% on December 1, 2019.  The remainder of the units will vest in twelve substantially equal quarterly installments thereafter.  The restricted stock units have no expiration date."}],"balance_after":131250,"derivative":{"underlying":"Common Stock","underlying_shares":43750},"source":{"system":"sec-edgar","filing":"0001453687-19-000168","document":"wf-form4_157540798248948.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368719000168/wf-form4_157540798248948.xml","form_type":"4"}},{"id":3354393,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-03T16:20:01.000Z","date":"2019-12-02","kind":"sale","acquired":false,"shares":14272,"price":1.5281,"value":21809.0432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $1.50 to $1.57. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":70914,"source":{"system":"sec-edgar","filing":"0001453687-19-000168","document":"wf-form4_157540798248948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368719000168/wf-form4_157540798248948.xml","form_type":"4"}},{"id":3354392,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-03T16:20:01.000Z","date":"2019-12-01","kind":"exercise","acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":85186,"source":{"system":"sec-edgar","filing":"0001453687-19-000168","document":"wf-form4_157540798248948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368719000168/wf-form4_157540798248948.xml","form_type":"4"}},{"id":3395421,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-10-09T16:19:28.000Z","date":"2019-10-07","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest as to 50% of the shares on October 7, 2020, and the remaining 50% of the shares on October 7, 2021."}],"balance_after":400000,"derivative":{"exercise_price":1.75,"expiration_date":"2029-10-06","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001453687-19-000145","document":"wf-form4_157065234617939.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368719000145/wf-form4_157065234617939.xml","form_type":"4"}},{"id":3433358,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-20T16:31:28.000Z","date":"2019-08-20","kind":"grant","acquired":true,"shares":41436,"price":1.81,"value":74999.16,"ownership":{"direct":true},"balance_after":41436,"source":{"system":"sec-edgar","filing":"0001453687-19-000121","document":"wf-form4_156633307237124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000145368719000121/wf-form4_156633307237124.xml","form_type":"4"}},{"id":3629328,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-27T16:30:21.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 25% on February 25, 2020. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":330000,"derivative":{"exercise_price":2.2,"expiration_date":"2029-02-24","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001760229-19-000002","document":"wf-form4_155130300495416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000176022919000002/wf-form4_155130300495416.xml","form_type":"4"}},{"id":3745917,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2018-12-03T08:39:42.000Z","date":"2018-12-01","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit vests as to 25% on December 1, 2019.  The remainder of the units will vest in twelve substantially equal quarterly installments thereafter.  The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit vests as to 25% on December 1, 2019.  The remainder of the units will vest in twelve substantially equal quarterly installments thereafter.  The restricted stock units have no expiration date."}],"balance_after":175000,"derivative":{"underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001410578-18-000585","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000141057818000585/a4.xml","form_type":"4"}},{"id":3745916,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":69769,"kind":"person","name":"Brunn Carsten","position":1,"cik":"0001760229","reported_name":"Brunn Carsten","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-03T08:39:42.000Z","date":"2018-12-01","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% on December 1, 2019.  The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":1000000,"derivative":{"exercise_price":6.03,"expiration_date":"2028-11-30","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001410578-18-000585","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760229/000141057818000585/a4.xml","form_type":"4"}}]}